Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult Turner syndrome: The impact of body composition, maximal oxygen uptake and treatment with sex hormones

被引:11
作者
Gravholt, CH
Veldhuis, JD
Christiansen, JS
机构
[1] Aarhus Univ Hosp, Med Res Labs, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Med Dept Endocrinol & Diabet M, DK-8000 Aarhus, Denmark
[3] Univ Virginia, NSF Ctr Biol Timing, Dept Internal Med, Interdisciplinary Grad Biophys Programme, Charlottesville, VA 22908 USA
[4] Univ Virginia, NSF Ctr Biol Timing, Dept Pharmacol, Interdisciplinary Grad Biophys Programme, Charlottesville, VA 22908 USA
关键词
Turner syndrome; adults; deconvolution analysis; approximate entropy; 24-h GH secretion; lean body mass; maximal oxygen uptake; female sex hormone replacement;
D O I
10.1016/S1096-6374(98)80124-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The objectives of this study were to (1) quantify pulsatility and orderliness of 24-h growth hormone (GH) secretion in adult Turner syndrome; (2) study the impact of sex steroid replacement therapy in adult Turner syndrome on these measures of GH secretion, and in addition examine the differential effect of oral vs transdermal estrogen administration on GH secretion patterns. To these ends, we used deconvolution analysis and approximate entropy (ApEn) to quantify GH release over 24 h in 21 patients with Turner syndrome before and during sex hormone substitution, compared to an age-matched control group. Deconvolution analysis revealed that the mass of GH secreted per burst and production rate was significantly lower in Turner patients compared to controls, resulting in a significantly lower integrated 24-h GH concentration. However, multiple stepwise regression revealed that lean body mass (LBM) and maximal oxygen uptake were significant discriminative variable, explaining a large part of the variation in mass secreted per burst (r= 0.72, P< 0.0005) and production rate (r= 0.73, P < 0.0005), while group (Turner or control) did not explain any of the difference. There was a significant difference in ApEn between Turner patients and controls, denoting more disorderly GH release in Turner syndrome. During administration of sex hormones, a significant increase was seen in basal secretion and GH secretory burst half-duration, as well as in integrated 24-h GH concentration. No change in ApEn was evident. We conclude that GH secretion in adult Turner syndrome is irregular, reduced in mass and production rate. The reduction in mass and production rate could be explained by differences in body composition and maximal oxygen uptake compared to relevant controls, while the irregularity of GH secretion was unexplained by the measured variables. We hypothesize that the increased irregularity could be attributable to low levels of circulating androgens or an increased biological age in the Turner patients. (C) 1998 Churchill Livingstone.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 38 条
[1]   SUBNORMAL PUBERTAL INCREASES OF SERUM ANDROGENS IN TURNERS SYNDROME [J].
APTER, D ;
LENKO, HL ;
PERHEENTUPA, J ;
SODERHOLM, A ;
VIHKO, R .
HORMONE RESEARCH, 1982, 16 (03) :164-173
[2]   QUALITY-OF-LIFE IN ADULTS WITH GROWTH-HORMONE (GH) DEFICIENCY - RESPONSE TO TREATMENT WITH RECOMBINANT HUMAN GH IN A PLACEBO-CONTROLLED 21-MONTH TRIAL [J].
BURMAN, P ;
BROMAN, JE ;
HETTA, J ;
WIKLUND, I ;
ERFURTH, EM ;
HAGG, E ;
KARLSSON, FA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3585-3590
[3]   Regulation of in vivo growth hormone secretion by leptin. [J].
Carro, E ;
Senaris, R ;
Considine, RV ;
Casanueva, FF ;
Dieguez, C .
ENDOCRINOLOGY, 1997, 138 (05) :2203-2206
[4]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[5]   A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum [J].
Fisker, S ;
Frystyk, J ;
Skriver, L ;
Vestbo, E ;
Ho, KKY ;
Orskov, H .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (09) :779-785
[6]   FREE INSULIN-LIKE GROWTH-FACTORS (IGF-I AND IGF-II) IN HUMAN SERUM [J].
FRYSTYK, J ;
SKJAERBAEK, C ;
DINESEN, B ;
ORSKOV, H .
FEBS LETTERS, 1994, 348 (02) :185-191
[7]   PULSATILE GROWTH-HORMONE RELEASE IN TURNERS SYNDROME AND SHORT NORMAL-CHILDREN [J].
GHIZZONI, L ;
LAMBORGHINI, A ;
ZIVERI, M ;
VOLTA, C ;
PANZA, C ;
BALESTRAZZI, P ;
BERNASCONI, S .
ACTA ENDOCRINOLOGICA, 1990, 123 (03) :291-297
[8]   Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone [J].
Giustina, A ;
Scalvini, T ;
Tassi, C ;
Desenzani, P ;
Poiesi, C ;
Wehrenberg, WB ;
Rogol, AD ;
Veldhuis, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1210-1219
[9]   Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol [J].
Gravholt, CH ;
Naeraa, RW ;
Fisker, S ;
Christiansen, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2570-2577
[10]  
Gravholt CH, 1997, AM J MED GENET, V72, P403